经角膜电刺激治疗视网膜色素变性患者:一项为期1年的前瞻性随机假刺激对照随访研究
本研究纳入52例视网膜色素变性(RP)患者,进行为期1年的前瞻性随机部分设盲假刺激对照研究,每周自行在家单眼接受30分钟经角膜电刺激(TES),随机分为假刺激组、150%或200%个体电刺激光幻视阈值(EPT)组。TES耐受良好,干眼症状(52例中31例)为主要不良事件;200%组视野面积仅呈防止视野丢失的趋势(P=0.24);200%组(P<0.0001)和150%组(P=0.006)明适应单闪光b波较假刺激组显著改善。结论认为每周在家自行TES的安全性及可接受耐受性在1年内得到确认,视网膜电图(ERG)客观测得的视网膜功能改善为TES对RP患者的潜在益处提供了支持。
要点
- 52例RP患者随机分为假刺激组、150%或200%个体EPT组,每周单眼TES 30分钟,持续52周。
- 干眼症状(52例中31例)为主要不良事件,TES耐受良好。
- 200%组明适应单闪光b波(P<0.0001)和150%组(P=0.006)较假刺激组显著改善。
核心结论
- 每周在家自行TES的安全性及可接受耐受性在1年内得到确认。
- ERG客观测得的视网膜功能改善为TES对RP患者的潜在益处提供了支持。
研究设计与样本
- 前瞻性、随机、部分设盲、假刺激对照随访研究,纳入52例RP患者,遵循良好临床实践规范。
- 经角膜电刺激(Okustim)单眼每周30分钟,连续52周,随机分为假刺激组、150%或200%个体EPT组。
主要发现
- TES耐受良好,干眼症状(52例中31例)为主要不良事件。
- 整个研究期间,200%组视野面积仅呈防止视野丢失的趋势(P=0.24)。
- 明适应单闪光b波:200%组(P<0.0001)和150%组(P=0.006)较假刺激组显著改善。
- 200%组暗适应b波振幅呈功能改善趋势(P=0.097)。
- 其他检查方法未达统计学显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: After promising results of an exploratory study, this study was designed to assess the safety and efficacy of transcorneal electrical stimulation (TES) over 1 year in patients with retinitis pigmentosa (RP). METHODS: We included 52 RP patients in this prospective, randomized, partially-masked study which was done in accordance with rules of good clinical practice. Transcorneal electrical stimulation by Okustim was applied monocularly for 30 minutes per week for 52 consecutive weeks. Patients were assigned randomly to the groups: sham, 150%, or 200% of individual electrical phosphene threshold (EPT). Visual acuity (retroilluminated Snellen charts), visual field (VF; Octopus 900), electroretinography (ERG), rod and cone full-field stimulus threshold, EPTs and IOP were assessed. Primary outcome measures were VF area; secondary outcome measures were development of ERG parameters. RESULTS: The application of TES was tolerated well. Dry eye symptoms (31 of 52 patients) were registered as the main adverse event. Throughout the study period, the VF area showed only a trend for prevention of VF loss in the 200% group (P = 0.24). A significant improvement of light-adapted single flash b-wave was noted for the 200% (P < 0.0001) and 150% (P = 0.006) groups compared to the sham group. Tendencies of improved function were observed for scotopic b-wave amplitude for the 200% group (P = 0.097). Other examination methods did not reach statistical significance. CONCLUSIONS: The safety and acceptable tolerability of weekly TES self-administered by patients at home was confirmed over the course of 1 year. Objectively measured improvements in retinal function with ERG provide support for the potential benefits of TES for RP patients.
引用
- Schatz A, Pach J, Gosheva M, et al. Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year. Invest Ophthalmol Vis Sci. 2017. PMID: 28114587. doi:10.1167/iovs.16-19906
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。